✦ LIBER ✦

3025 Determinants of pain response in patients (pts) with skeletal metastases receiving zoledronic acid (ZOL)

✍ Scribed by T. Van den Wyngaert; P. Duprez; L. Marcelis; C. Mitine; C. Focan; J. Kerger; F. Geurs; R. Kalantari; I. Lechat

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Zoledronic acid (zol) provides long-term

✍ H. Löthman; S. Heatley; A. Lipton 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 48 KB

572Long-term reduction of bone pain and

✍ F. Saad; J. Eastham; J. McKieman; D. Gleason; M. Zheng 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 198 KB

PCN78 COST-EFFECTIVENESS ASSESSMENT OF Z

✍ MF Botteman; JFS Logman; S Kaura 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

P79. N-Telopeptide of type I collagen (N

✍ Vera Hirsh; Pierre Major; Allan Lipton; Richard Cook; Corey Langer; Matthew Smit 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 32 KB